Deworming Against Tuberculosis

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate whether treatment against intestinal helminths in patients with pulmonary tuberculosis undergoing chemotherapy could improve the clinical outcome by enhancing host immunity.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Linkoeping University
• Collaborators: Armauer Hansen Research Institute, Ethiopia; University of Gondar
• Treatments: Albendazole

Criteria

Inclusion Criteria:

• Informed and written consent to take part in the study

• Newly diagnosed pulmonary TB patients according to the WHO definitions of active tuberculosis who have a positive stool sample for helminths other than Schistosoma spp.

Exclusion Criteria:

• Pregnancy

• Corticosteroid or antibiotic treatment

• Symptomatic (diarrhoea) infection caused by worm infection

• Chronic diseases or acute infectious diseases other than TB or HIV

• Stool sample positive for Schistosoma spp